GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Vital KSK Holdings Inc (TSE:3151) » Definitions » EV-to-EBIT

Vital KSK Holdings (TSE:3151) EV-to-EBIT : 3.18 (As of May. 12, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Vital KSK Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vital KSK Holdings's Enterprise Value is 円37,151 Mil. Vital KSK Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円11,700 Mil. Therefore, Vital KSK Holdings's EV-to-EBIT for today is 3.18.

The historical rank and industry rank for Vital KSK Holdings's EV-to-EBIT or its related term are showing as below:

TSE:3151' s EV-to-EBIT Range Over the Past 10 Years
Min: -0.49   Med: 5.57   Max: 17.96
Current: 3.18

During the past 13 years, the highest EV-to-EBIT of Vital KSK Holdings was 17.96. The lowest was -0.49. And the median was 5.57.

TSE:3151's EV-to-EBIT is ranked better than
92.5% of 80 companies
in the Medical Distribution industry
Industry Median: 13.59 vs TSE:3151: 3.18

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Vital KSK Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was 円30,575 Mil. Vital KSK Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円11,700 Mil. Vital KSK Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 38.27%.


Vital KSK Holdings EV-to-EBIT Historical Data

The historical data trend for Vital KSK Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vital KSK Holdings EV-to-EBIT Chart

Vital KSK Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.79 6.25 12.54 3.24 4.71

Vital KSK Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.45 4.71 3.96 3.18 2.61

Competitive Comparison of Vital KSK Holdings's EV-to-EBIT

For the Medical Distribution subindustry, Vital KSK Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vital KSK Holdings's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Vital KSK Holdings's EV-to-EBIT falls into.



Vital KSK Holdings EV-to-EBIT Calculation

Vital KSK Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=37150.967/11700
=3.18

Vital KSK Holdings's current Enterprise Value is 円37,151 Mil.
Vital KSK Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円11,700 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vital KSK Holdings  (TSE:3151) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Vital KSK Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=11700/30575.2504
=38.27 %

Vital KSK Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was 円30,575 Mil.
Vital KSK Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円11,700 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vital KSK Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Vital KSK Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Vital KSK Holdings (TSE:3151) Business Description

Traded in Other Exchanges
N/A
Address
1-1-12 Tsurumaki, Setagaya-ku, JPN, 154-0016
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.

Vital KSK Holdings (TSE:3151) Headlines

No Headlines